Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Federico

Showing results (51-60 of 271) with videos related to

Pageof 28
Sort By:
Current Hematologic Malignancy Reports|October 10, 2015
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell ProjectMonica Bellei, Chadi Nabhan, Emanuela Anna Pesce, et al.
International Journal of Molecular Sciences|April 18, 2013
Ovarian cancer: can proteomics give new insights for therapy and diagnosis?Angela Toss, Elisabetta De Matteis, Elena Rossi, et al.
Leukemia & Lymphoma|February 25, 2014
The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphomaPier Luigi Zinzani, Massimo Federico, Stefano Oliva, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2005
In situ breast cancer: incidence trend and organised screening programmes in ItalyAlessandro Barchielli, Massimo Federico, Vincenzo De Lisi, et al.
European Journal of Radiology|October 23, 2012
MRI in high risk women: benefits and problemsLaura Cortesi, Annarita Pecchi, Elisabetta De Matteis, et al.
Oncology Reports|July 4, 2012
Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parametersPaolo G Gobbi, Manuela Bergonzi, Emilio Bassi, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 22, 2015
Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position PaperPier Luigi Zinzani, Paolo Corradini, Alessandro M Gianni, et al.
BMC Cancer|March 12, 2010
Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancerLaura Cortesi, Cristina Masini, Claudia Cirilli, et al.
BMC Cancer|December 22, 2007
Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based studyClaudia Mucciarini, Giulio Rossi, Federica Bertolini, et al.
Cancer Causes & Control : CCC|November 8, 2002
Changes in breast cancer incidence and stage distribution in Modena, Italy: the effect of a mammographic screening programDaniela Turchetti, Lucia Mangone, Rossella Negri, et al.
Pageof 28

Showing results (51-60 of 271) with videos related to

Sort By:
Pageof 28
Current Hematologic Malignancy Reports|October 10, 2015
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell ProjectMonica Bellei, Chadi Nabhan, Emanuela Anna Pesce, et al.
International Journal of Molecular Sciences|April 18, 2013
Ovarian cancer: can proteomics give new insights for therapy and diagnosis?Angela Toss, Elisabetta De Matteis, Elena Rossi, et al.
Leukemia & Lymphoma|February 25, 2014
The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphomaPier Luigi Zinzani, Massimo Federico, Stefano Oliva, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2005
In situ breast cancer: incidence trend and organised screening programmes in ItalyAlessandro Barchielli, Massimo Federico, Vincenzo De Lisi, et al.
European Journal of Radiology|October 23, 2012
MRI in high risk women: benefits and problemsLaura Cortesi, Annarita Pecchi, Elisabetta De Matteis, et al.
Oncology Reports|July 4, 2012
Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parametersPaolo G Gobbi, Manuela Bergonzi, Emilio Bassi, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 22, 2015
Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position PaperPier Luigi Zinzani, Paolo Corradini, Alessandro M Gianni, et al.
BMC Cancer|March 12, 2010
Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancerLaura Cortesi, Cristina Masini, Claudia Cirilli, et al.
BMC Cancer|December 22, 2007
Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based studyClaudia Mucciarini, Giulio Rossi, Federica Bertolini, et al.
Cancer Causes & Control : CCC|November 8, 2002
Changes in breast cancer incidence and stage distribution in Modena, Italy: the effect of a mammographic screening programDaniela Turchetti, Lucia Mangone, Rossella Negri, et al.
Pageof 28